COMPOUND AND USE THEREOF IN TREATMENT OF TREG-RELATED DISEASES
A compound and use thereof in the treatment of Treg-related diseases, particularly in diseases where increasing the quantity of Treg cells is beneficial for prevention and/or treatment. By means of experiments, it is found that O-1602 can effectively promote Treg proliferation, increasing the quanti...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English French |
Published |
06.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A compound and use thereof in the treatment of Treg-related diseases, particularly in diseases where increasing the quantity of Treg cells is beneficial for prevention and/or treatment. By means of experiments, it is found that O-1602 can effectively promote Treg proliferation, increasing the quantity of Treg cells, which is beneficial for the prevention or treatment of some diseases, such as autoimmune diseases, allergic diseases, transplant rejection reactions, graft-versus-host disease (GvHD), and inflammatory diseases. The compound is anticipated for use via diverse routes of administration, possessing great application and research value.
L'invention concerne un composé et son utilisation dans le traitement de maladies associées au Treg, en particulier dans des maladies dans lesquelles l'augmentation de la quantité de lymphocytes Treg est bénéfique pour la prévention et/ou le traitement. Au moyen d'expériences, il a été découvert que O-1602 peut favoriser efficacement la prolifération des Treg, augmenter |
---|---|
Bibliography: | Application Number: WO2023CN135912 |